Indication

HTLV-1-Associated Myelopathy (HAM)

1 clinical trial

2 products

Clinical trial

A Clinical Pharmacological Study of MT-3921 in Subjects With Human T-cell Leukemia Virus Type 1 (HTLV-1)-Associated Myelopathy (HAM)

Status: Completed, Estimated PCD: 2023-09-14

Product

Product